| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| PPP1R2C |
O14990
|
PPP1R2C family member C
|
Enzyme modulator
|
|
0.478 |
0.846 |
| MIR206 |
|
microRNA 206
|
|
|
0.477 |
0.846 |
| MIR451A |
|
microRNA 451a
|
|
|
0.505 |
0.769 |
| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| VN1R17P |
Q8TDU5
|
vomeronasal 1 receptor 17 pseudogene
|
|
|
0.529 |
0.923 |
| MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| GPR166P |
|
G protein-coupled receptor 166 pseudogene
|
|
|
0.531 |
0.923 |
| LINC02210-CRHR1 |
P34998
|
LINC02210-CRHR1 readthrough
|
|
|
0.570 |
0.692 |
| THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
| RSS |
|
Russell Silver syndrome
|
|
|
0.578 |
0.692 |
| LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
| LINC00273 |
|
long intergenic non-protein coding RNA 273
|
|
|
0.585 |
0.846 |
| SMCP |
P49901
|
sperm mitochondria associated cysteine rich protein
|
|
|
0.621 |
0.692 |
| PSS |
|
Potocki-Shaffer syndrome
|
|
|
0.608 |
0.654 |
| PANDAR |
|
promoter of CDKN1A antisense DNA damage activated RNA
|
|
|
0.623 |
0.577 |
| MIR124-1 |
|
microRNA 124-1
|
|
|
0.663 |
0.500 |
| CRYBG1 |
Q9Y4K1
|
crystallin beta-gamma domain containing 1
|
|
3.5E-33 |
0.743 |
0.462 |
| LAMA1 |
P25391
|
laminin subunit alpha 1
|
|
3.2E-32 |
0.582 |
0.808 |
| LRRK2 |
Q5S007
|
leucine rich repeat kinase 2
|
Kinase
|
2.6E-30 |
0.510 |
0.808 |
| BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
| PKD2L1 |
Q9P0L9
|
polycystin 2 like 1, transient receptor potential cation channel
|
Ion channel
|
1.6E-27 |
0.565 |
0.731 |
| BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
| AMPD1 |
P23109
|
adenosine monophosphate deaminase 1
|
Enzyme
|
1.9E-21 |
0.573 |
0.692 |